SPON1 and Alzheimer disease: Although SMOC1 and SPON1 have been reported to change in AD plasma using antibody- or aptamer-based proteomic technologies [30], members of M42 have been extremely difficult to identify and quantify using mass spectrometry (MS)-based proteomic approaches in plasma.